Skip to content
Portrait of Stephanie Nolen

Stephanie Nolen

Stephanie Nolen covers global health for The New York Times. She has reported on public health, economic development and humanitarian crises from more than 80 countries around the world.

  1. Money, Sex and Rumors: Tanzania Faces Challenges to Protect Girls From HPV

    Almost all cervical cancer deaths now occur in developing countries. Tanzania is trying to inoculate girls against the virus that causes the disease — nearly 20 years after rich countries began offering the shot.

    By Stephanie Nolen

     

  2. La OMS declara el fin de la COVID-19 como emergencia internacional de salud

    “La fase de emergencia ha terminado, pero la covid no”, dijo una funcionaria de la OMS. La decisión cambia poco en la práctica pero es un momento significativo.

    By Stephanie Nolen

    Read in English
     

  3. W.H.O. Ends Global Health Emergency Designation for Covid

    The decision has little practical effect but is a significant moment in the struggle against a virus that has killed millions and upended lives throughout the world.

    By Stephanie Nolen

    Leer en español
     
  4. Global Health

    Can Africa Get Close to Vaccine Independence? Here’s What It Will Take.

    Leaders on the continent have vowed that if there is another pandemic, they won’t be shut out of the vaccine market.

    By Stephanie Nolen

     

  5. New Marburg Outbreaks in Africa Raise Alarm About the Deadly Virus’s Spread

    The spread of the Ebola-like virus has claimed lives but could be a crucial chance to test a vaccine — if supplies and researchers are mobilized in time.

    By Stephanie Nolen

     
  6. Global Health

    African Countries Made Huge Gains in Life Expectancy. Now That Could Be Erased.

    Incidence of illnesses such as diabetes and hypertension is climbing quickly in most sub-Saharan countries, but the conditions are rarely diagnosed or treated.

    By Stephanie Nolen

     

  7. When a ‘Miracle’ Drug Is Out of Reach

    People in poorer countries cannot get access to a revolutionary cystic fibrosis treatment.

    By Stephanie Nolen and Rebecca Robbins

     

  8. The Drug Is a ‘Miracle’ but These Families Can’t Get It

    Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.

    By Stephanie Nolen and Rebecca Robbins

     

  9. Fabricantes de vacunas contra la covid se quedaron con 1400 millones de dólares en anticipos por pedidos cancelados

    El programa responsable de vacunar a los pobres del mundo ha estado negociando para tratar de cancelar sus acuerdos con las farmacéuticas por las dosis que ya no necesita, según documentos confidenciales.

    By Stephanie Nolen and Rebecca Robbins

    Read in English
     

  10. Vaccine Makers Kept $1.4 Billion in Prepayments for Canceled Covid Shots for the World’s Poor

    Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.

    By Stephanie Nolen and Rebecca Robbins

    Leer en español